Affimed Stock: Preparing For Key Inflection Points (NASDAQ:AFMD)
Marcin Klapczynski/iStock via Getty Images Over the past few years, Affimed (NASDAQ:AFMD) has constructed a distinguished pipeline of innate cell engagers and has verified their three-pronged development strategy to move the company closer to the […]
